These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2986647)
1. Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. Palmer RM; Salmon JA Biochem Pharmacol; 1985 May; 34(9):1485-90. PubMed ID: 2986647 [TBL] [Abstract][Full Text] [Related]
2. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187. Palmer RM; Salmon JA Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. Elliott GR; Lauwen AP; Bonta IL Br J Pharmacol; 1989 Feb; 96(2):265-70. PubMed ID: 2538186 [TBL] [Abstract][Full Text] [Related]
4. Calcium ionophore potentiates chemotactic peptide and platelet activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils. Tanizawa H; Tai HH Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):45-9. PubMed ID: 2169061 [TBL] [Abstract][Full Text] [Related]
5. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function. Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681 [TBL] [Abstract][Full Text] [Related]
6. Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils. Tanizawa H; Tai HH Biochem Pharmacol; 1989 Aug; 38(15):2559-63. PubMed ID: 2547385 [TBL] [Abstract][Full Text] [Related]
7. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4. Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028 [TBL] [Abstract][Full Text] [Related]
8. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Ozaki Y; Ohashi T; Niwa Y Biochem Pharmacol; 1986 Oct; 35(20):3481-8. PubMed ID: 3021173 [TBL] [Abstract][Full Text] [Related]
9. Stimulus-dependent effects of CI-986 on arachidonic acid metabolism by human neutrophils. Wright CD; Kennedy JA; Kuipers PJ; Ferin MA Inflamm Res; 1995 Feb; 44(2):74-8. PubMed ID: 7655988 [TBL] [Abstract][Full Text] [Related]
10. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites. Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161 [TBL] [Abstract][Full Text] [Related]
11. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release. Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972 [TBL] [Abstract][Full Text] [Related]
12. Requirement of free arachidonic acid for leukotriene B4 biosynthesis by 12-hydroperoxyeicosatetraenoic acid-stimulated neutrophils. Kanaji K; Okuma M; Sugiyama T; Sensaki S; Ushikubi F; Uchino H Biochem Biophys Res Commun; 1986 Jul; 138(2):589-95. PubMed ID: 3017333 [TBL] [Abstract][Full Text] [Related]
13. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition. Fitzgerald MF; Parente L; Whittle BJ Eur J Pharmacol; 1989 May; 164(3):539-46. PubMed ID: 2548873 [TBL] [Abstract][Full Text] [Related]
14. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils. Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959 [TBL] [Abstract][Full Text] [Related]
15. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions. Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase. Salmon JA; Tilling LC; Moncada S Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation. Beckman JK; Gay JC; Brash AR; Lukens JN; Oates JA Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions. Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037 [TBL] [Abstract][Full Text] [Related]
19. Lipoxins A4 and B4 inhibit leukotriene B4 generation from human neutrophil leukocyte suspensions. Conti P; Reale M; Barbacane RC; Bongrazio M; Panara MR Immunol Lett; 1990 Jul; 24(4):237-42. PubMed ID: 2167876 [TBL] [Abstract][Full Text] [Related]
20. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents. Rosenthal MD; Franson RC J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]